Precise activation and tracking of cancer treatment with a n

This class of inhibitors has shown therapeutic promise in several cancer types, including chronic lymphocytic leukemia and Burkitt lymphoma

Related Keywords

Texas , United States , America , Texans , Dylan Horton , Kimberlee Speakman , Wistar Institute , University Of South Florida , Microenvironment Metastasis Program , South Florida , Metastasis Program , Enhanced Anticancer Compound May Allow , Precise Activation , Good Morning America ,